BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA™ Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

  June 22, 2026

   · 

  7 min read
• Press Releases

  NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression

  June 22, 2026

   · 

  7 min read
• Press Releases

  Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)

  June 22, 2026

   · 

  10 min read
• Press Releases

  MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

  June 22, 2026

   · 

  8 min read
• Press Releases

  Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

  June 22, 2026

   · 

  5 min read
• Press Releases

  Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus

  June 22, 2026

   · 

  10 min read
• Press Releases

  Endure Biotherapeutics Receives NSF SBIR Phase I Grant for Phenylketonuria (PKU) Program and Reports Pig Study validates Engineered Native Bacteria platform technology

  June 22, 2026

   · 

  3 min read
• Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson

  June 22, 2026

   · 

  5 min read
• Press Releases

  Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

  June 22, 2026

   · 

  6 min read
• Press Releases

  AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

  June 22, 2026

   · 

  17 min read